SCHEMBL7697888

SCHEMBL7697888

O=C(Nc1ccc(-c2n[nH]c3c2Cc2ccccc2-3)cc1)c1ccccc1F

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 6/20 0.57
KDR P35968 2/20 0.56
CDK1 P06493 1/20 0.53
CDK2 P24941 1/20 0.53
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
TDP1 Q9NUW8 1/20 0.50
LMNA P02545 1/20 0.47
SMN1; SMN2 Q16637 4/20 0.45
HTT P42858 3/20 0.45
NPC1 O15118 3/20 0.45
RAB9A P51151 3/20 0.45
MAPT P10636 4/20 0.45
ALDH1A1 P00352 2/20 0.45
RXFP1 Q9HBX9 1/20 0.45
TP53 P04637 2/20 0.43
PTPRC P08575 2/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43
RELA Q04206 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7702848 0.93 CHEK1 (0.54) CHEK1KDRCDK1CDK2MEN1
SCHEMBL7702867 0.90 CHEK1 (0.53) CHEK1KDRCDK1CDK2TDP1
SCHEMBL7700585 0.90 CHEK1 (0.53) CHEK1KDRCDK1CDK2LMNA
SCHEMBL6998221 0.88 NPC1 (0.52) CHEK1KDRMEN1KMT2ATDP1
SCHEMBL7696243 0.85 CHEK1 (0.57) CHEK1KDRCDK1CDK2MEN1
SCHEMBL7094928 0.85 KDR (0.64) CHEK1KDRCDK1CDK2MEN1
SCHEMBL7091231 0.84 CHEK1 (0.56) CHEK1KDRCDK1CDK2
Water SCHEMBL7089950 0.84 KDR (0.63) CHEK1KDRCDK1CDK2MEN1
SCHEMBL7705309 0.83 KDR (0.69) CHEK1KDRCDK1CDK2NPC1
SCHEMBL7093397 0.83 CHEK1 (0.54) CHEK1KDRCDK1CDK2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6462036-B1 INHIBITING SIGNAL TRANSDUCTION BY MODULATING ACTIVITY OF RECEPTOR AND NONRECEPTOR TYROSINE AND SERINE/THREONINE KINASES TO REGULATE AND MODULATE ABNORMAL OR INAPPROPRIATE CELL PROLIFERATION, DIFFERENTIATION, OR METABOLISM BASF AKTIENGESELLSCHAFT (DE) 2002-10-08 US disclosed